21-hydroxylase deficiency natural history, complications and prognosis
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency natural history, complications and prognosis |
FDA on 21-hydroxylase deficiency natural history, complications and prognosis |
CDC on 21-hydroxylase deficiency natural history, complications and prognosis |
21-hydroxylase deficiency natural history, complications and prognosis in the news |
Blogs on 21-hydroxylase deficiency natural history, complications and prognosis |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
The prognosis of 21-hydroxylase deficient congenital adrenal hyperplasia is usually good, if left untreated, it usually leads to adrenal crisis which is fatal.
Complications
Complication associated with 21-hydroxylase deficient congenital adrenal hyperplasia include:
- Adrenal crisis
- Infertility
- Pre-cautious puberty
- Virilization
Prognosis
Prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is usually good. But when adrenal crisis happens and is untreated, the patient may die within 1~6 weeks after birth.